Healthy Adult Volunteer Study of Intraosseous Infusion Using the Sternum
- Conditions
- Intraosseous Vascular Access
- Registration Number
- NCT01853215
- Lead Sponsor
- Vidacare Corporation
- Brief Summary
This study is being done to evaluate intraosseous vascular access through the sternum.
- Detailed Description
The purpose of this study is to evaluate the presence or absence of extravasation when using the T.A.L.O.N. Intraosseous System to establish sternal intraosseous infusion. This study will also evaluate the user preference feedback received from the device operators about the ease of use and level of satisfaction with the device. Lastly, this study will evaluate the infusion flow rates obtained when using intraosseous infusion in the sternum.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
- 21 years of age or older;
- healthy adult subjects
- Weight < 45kg;
- BMI greater or equal to 30 with absence of adequate landmarks or too much overlaying tissue, as determined by the PI;
- Imprisoned subjects;
- pregnant subjects;
- prior sternotomy;
- cognitively impaired subjects;
- fracture in target bone, or significant trauma to the site;
- excessive tissue and/or absence of adequate anatomical landmarks in target bone;
- infection in target area;
- IO insertion in past 48 hours or other significant orthopedic procedure in target bone;
- current use of anti-coagulants;
- previous adverse reaction to Lidocaine;
- current cardiac condition requiring pacemaker or anti-arrhythmic drugs
- previous adverse reaction to contrast dye
- Allergy to any food and drug
- History of impaired renal function
- History of impaired hepatic function
- History of cardiac disease
- History of pheochromocytoma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Occurrences of Extravasation During Infusion during 12 minutes of infusion The number of occurrences of extravasation with intraosseous infusion as evidenced by contrast injection into the intraosseous catheter, visualized under fluoroscopic imaging.
- Secondary Outcome Measures
Name Time Method Gravity Flow Rates during the 12 minute infusion time frame Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a gravity infusion (no Pressure).
100mmHg Infusion Flow Rates during the 12 minute infusion time frame Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 100 mmHg infusion.
200mmHg Infusion Flow Rates during the 12 minute infusion time frame Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 200 mmHg infusion.
300mmHg Infusion Flow Rates during the 12 minute infusion time frame Measure the infusion flow rates attainable in the sternum when using intraosseous infusion of normal saline using a 300 mmHg infusion.
Stability of Locator During insertion of the intraosseous needle set Operator's perceived stability of the sternal locator once placed on the subject.
1 to 5 scale was used with 1=Poor; 2=Fair; 3=Good; 4=Very good; 5=Excellent.Stability of Catheter Hub During insertion of the intraosseous needle set Ability to stabilize the catheter hub and rotate the stylet for removal. 1 to 5 scale was used with 1=Very difficult; 2-Difficult; 3=Neutral; 4=Easy; 5=Very easy.
Adhesion Strips During insertion of the intraosseous needle set Perceived effeciveness of the device adhesion strips after application. A 1- 5 scale was used with 1=Poor; 2=Fair; 3=Good; $=Very good; 5=Excellent.
Trial Locations
- Locations (1)
Bulverde-Spring Branch EMS
🇺🇸Spring Branch, Texas, United States
Bulverde-Spring Branch EMS🇺🇸Spring Branch, Texas, United States